Approval · Notice of Compliance 37173 · 2026
LEVOCARNITINE INJECTION: Notice of Compliance 37173
Issued March 25, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37173
- Date
- March 25, 2026
- Company
- Juno Pharma Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- CARNITOR (Leadiant Biosciences, Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVOCARNITINE INJECTION | 02566958 | Approved |
Medicinal ingredients
- LEVOCARNITINE 200 MG per ML